National Health (Germany) Price Prediction

WX6 Stock   61.00  0.50  0.83%   
The value of RSI of National Health's the stock price is slightly above 61. This entails that the stock is rather overbought by investors at this time. The main point of the Relative Strength Index (RSI) is to track how fast people are buying or selling National, making its price go up or down.

Oversold Vs Overbought

61

 
Oversold
 
Overbought
National Health Investors stock price prediction is an act of determining the future value of National Health shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of National Health's future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of National Health and does not consider all of the tangible or intangible factors available from National Health's fundamental data. We analyze noise-free headlines and recent hype associated with National Health Investors, which may create opportunities for some arbitrage if properly timed.
It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of National Health based on different types of headlines from major news networks to social media. The National stock price prediction module provides an analysis of price elasticity to changes in media outlook on National Health over a specific investment horizon. Using National Health hype-based prediction, you can estimate the value of National Health Investors from the perspective of National Health response to recently generated media hype and the effects of current headlines on its competitors.
This module is based on analyzing investor sentiment around taking a position in National Health. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in National Health to buy its stock at a price that has no basis in reality. In that case, they are not buying National because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

National Health after-hype prediction price

    
  EUR 60.5  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out National Health Basic Forecasting Models to cross-verify your projections.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of National Health's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Intrinsic
Valuation
LowRealHigh
54.4567.7469.36
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as National Health. Your research has to be compared to or analyzed against National Health's peers to derive any actionable benefits. When done correctly, National Health's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in National Health Investors.

National Health After-Hype Price Prediction Density Analysis

As far as predicting the price of National Health at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in National Health or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of National Health, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

National Health Estimiated After-Hype Price Volatility

In the context of predicting National Health's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on National Health's historical news coverage. National Health's after-hype downside and upside margins for the prediction period are 58.88 and 62.12, respectively. We have considered National Health's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
61.00
60.50
After-hype Price
62.12
Upside
National Health is very steady at this time. Analysis and calculation of next after-hype price of National Health Investors is based on 3 months time horizon.

National Health Stock Price Prediction Analysis

Have you ever been surprised when a price of a Company such as National Health is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading National Health backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with National Health, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.39 
1.62
 0.00  
 0.00  
0 Events / Month
0 Events / Month
Any time
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
61.00
60.50
0.00 
0.00  
Notes

National Health Hype Timeline

National Health Investors is at this time traded for 61.00on Stuttgart Exchange of Germany. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. National is projected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is projected to be very small, whereas the daily expected return is at this time at 0.39%. %. The volatility of related hype on National Health is about 0.0%, with the expected price after the next announcement by competition of 61.00. The company has Price to Book (P/B) ratio of 1.82. Historically many companies with similar price-to-book (P/B) ratio do better than the market in the long run. National Health Investors had not issued any dividends in recent years. Assuming the 90 days trading horizon the next projected press release will be any time.
Check out National Health Basic Forecasting Models to cross-verify your projections.

National Health Related Hype Analysis

Having access to credible news sources related to National Health's direct competition is more important than ever and may enhance your ability to predict National Health's future price movements. Getting to know how National Health's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how National Health may potentially react to the hype associated with one of its peers.

National Health Additional Predictive Modules

Most predictive techniques to examine National price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for National using various technical indicators. When you analyze National charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About National Health Predictive Indicators

The successful prediction of National Health stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as National Health Investors, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of National Health based on analysis of National Health hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to National Health's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to National Health's related companies.

Story Coverage note for National Health

The number of cover stories for National Health depends on current market conditions and National Health's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that National Health is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about National Health's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Other Macroaxis Stories

Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios

National Health Short Properties

National Health's future price predictability will typically decrease when National Health's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of National Health Investors often depends not only on the future outlook of the potential National Health's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. National Health's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding43.4 M
Dividends Paid161.8 M
When determining whether National Health Investors offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of National Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of National Health Investors Stock. Outlined below are crucial reports that will aid in making a well-informed decision on National Health Investors Stock:
Check out National Health Basic Forecasting Models to cross-verify your projections.
You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.

Complementary Tools for National Stock analysis

When running National Health's price analysis, check to measure National Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy National Health is operating at the current time. Most of National Health's value examination focuses on studying past and present price action to predict the probability of National Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move National Health's price. Additionally, you may evaluate how the addition of National Health to your portfolios can decrease your overall portfolio volatility.
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Money Managers
Screen money managers from public funds and ETFs managed around the world
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Please note, there is a significant difference between National Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if National Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, National Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.